FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yoshiaki Tokano

Research Profile

Disorders

Procedures

Chemicals & Drugs

Physiology

Lymphocyte Activation

Concepts & Ideas

Biological Markers

Anatomy

Co-author Network

Publications

TOP 3
Kentaro Minowa; Shinji Morimoto; Souichiro Nakano; Yutaka Nakiri; Eri Amano; Hirofumi Amano; Seiichiro Ando; Yoshiaki Tokano; Takashi Watanabe; Yoshinari Takasaki
Elevated serum level of circulating syndecan-1 (CD138) in active systemic lupus erythematosus.
Seiichiro Ando; Hirofumi Amano; Eri Amano; Kentaro Minowa; Takashi Watanabe; Soichiro Nakano; Yutaka Nakiri; Shinji Morimoto; Yoshiaki Tokano; Qingshun Lin; Rong Hou; Mareki Ohtsuji; Hiromichi Tsurui; Sachiko Hirose; Yoshinari Takasaki
FTY720 exerts a survival advantage through the prevention of end-stage glomerular inflammation in lupus-prone BXSB mice.
Kentaro Minowa; Yutaka Nakiri; Shouseki Lee; Hirofumi Amano; Shinji Morimoto; Naoto Tamura; Yoshiaki Tokano; Yoshinari Takasaki
[Examination of availability of the criteria for protective therapy against Pneumocystis pneumonia].

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yoshiaki Tokano (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Kentaro Minowa; Shinji Morimoto; Souichiro Nakano; Yutaka Nakiri; Eri Amano; Hirofumi Amano; Seiichiro Ando; Yoshiaki Tokano; Takashi Watanabe; Yoshinari Takasaki
Elevated serum level of circulating syndecan-1 (CD138) in active systemic lupus erythematosus.
Autoimmunity 2011;44(5):357-62.
2010: Seiichiro Ando; Hirofumi Amano; Eri Amano; Kentaro Minowa; Takashi Watanabe; Soichiro Nakano; Yutaka Nakiri; Shinji Morimoto; Yoshiaki Tokano; Qingshun Lin; Rong Hou; Mareki Ohtsuji; Hiromichi Tsurui; Sachiko Hirose; Yoshinari Takasaki
FTY720 exerts a survival advantage through the prevention of end-stage glomerular inflammation in lupus-prone BXSB mice.
Biochemical and biophysical research communications 2010;394(3):804-10.
2009: Kentaro Minowa; Yutaka Nakiri; Shouseki Lee; Hirofumi Amano; Shinji Morimoto; Naoto Tamura; Yoshiaki Tokano; Yoshinari Takasaki
[Examination of availability of the criteria for protective therapy against Pneumocystis pneumonia].
Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology 2009;32(4):256-62.
2009: Shinji Morimoto; Yoshiaki Tokano; Souichiro Nakano; Takashi Watanabe; Yoshihiro Tamayama; Akiko Mitsuo; Jun Suzuki; Hiroshi Kaneko; Iwao Sekigawa; Yoshinari Takasaki
Chemoattractant mechanism of Th1 cells in class III and IV lupus nephritis.
Autoimmunity 2009;42(2):143-9.
2008: Jun Abe; Satoshi Ueha; Jun Suzuki; Yoshiaki Tokano; Kouji Matsushima; Sho Ishikawa
Increased Foxp3(+) CD4(+) regulatory T cells with intact suppressive activity but altered cellular localization in murine lupus.
The American journal of pathology 2008;173(6):1682-92.
2008: Hirofumi Amano; N Furuhata; Naoto Tamura; Yoshiaki Tokano; Yoshinari Takasaki
Hypocomplementemic urticarial vasculitis with Jaccoud's arthropathy and valvular heart disease: case report and review of the literature.
Lupus 2008;17(9):837-41.
2008: Souichiro Nakano; Shinji Morimoto; Jun Suzuki; Kazuhisa Nozawa; Hirofumi Amano; Yoshiaki Tokano; Yoshinari Takasaki
Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
Rheumatology (Oxford, England) 2008;47(2):145-9.
2008: Akira Katagiri; Shinji Morimoto; Yutaka Nakiri; Souichiro Nakano; Akiko Mitsuo; Jun Suzuki; Hirofumi Amano; Kazuhisa Nozawa; Masanao Asano; Yoshiaki Tokano; Hiroshi Hashimoto; Yoshinari Takasaki
Decrease in CD4+CD25+ and CD8+CD28+ T cells in interstitial pneumonitis associated with rheumatic disease.
Modern rheumatology / the Japan Rheumatism Association 2008;18(6):562-9.
2008: T Watanabe; Jun Suzuki; Akiko Mitsuo; Souichiro Nakano; Y Tamayama; A Katagiri; Hirofumi Amano; Shinji Morimoto; Yoshiaki Tokano; Yoshinari Takasaki
Striking alteration of some populations of T/B cells in systemic lupus erythematosus: relationship to expression of CD62L or some chemokine receptors.
Lupus 2008;17(1):26-33.
2007: Yutaka Nakiri; Kentarou Minowa; Jun Suzuki; Akiko Mitsuo; Hirofumi Amano; Shinji Morimoto; Yoshiaki Tokano; Yoshinari Takasaki
Expression of CD22 on peripheral B cells in patients with rheumatoid arthritis: relation to CD5-positive B cells.
Clinical rheumatology 2007;26(10):1721-3.
2007: Shinji Morimoto; Souichiro Nakano; T Watanabe; Y Tamayama; Akiko Mitsuo; Yutaka Nakiri; Jun Suzuki; Kazuhisa Nozawa; Hirofumi Amano; Yoshiaki Tokano; Tetsuji Kobata; Yoshinari Takasaki
Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Rheumatology (Oxford, England) 2007;46(7):1083-6.
2007: Souichiro Nakano; Shinji Morimoto; Jun Suzuki; Akiko Mitsuo; Yutaka Nakiri; Akira Katagiri; Kazuhisa Nozawa; Hirofumi Amano; Yoshiaki Tokano; Hiroshi Hashimoto; Yoshinari Takasaki
Down-regulation of CD72 and increased surface IgG on B cells in patients with lupus nephritis.
Autoimmunity 2007;40(1):9-15.
2006: Akiko Mitsuo; Shinji Morimoto; Yutaka Nakiri; Jun Suzuki; Hiroshi Kaneko; Yoshiaki Tokano; Hiroshi Tsuda; Yoshinari Takasaki; Hiroshi Hashimoto
Decreased CD161+CD8+ T cells in the peripheral blood of patients suffering from rheumatic diseases.
Rheumatology (Oxford, England) 2006;45(12):1477-84.
2006: Jun Suzuki; Souichiro Nakano; Yutaka Nakairi; Akiko Mitsuo; Hirofumi Amano; Shinji Morimoto; Yoshiaki Tokano; Yoshinari Takasaki
CD19/22 balance relates to improvement of disease activity in systemic lupus erythematosus.
Modern rheumatology / the Japan Rheumatism Association 2006;16(4):235-8.
2005: Yoshiaki Tokano; Shinji Morimoto; Hirofumi Amano; Toshiaki Kawanishi; Tetsuro Yano; Masayuki Tomyo; Masahiro Sugawara; Shigeto Kobayashi; Hiroshi Tsuda; Yoshinari Takasaki; Hiroshi Hashimoto
The relationship between initial clinical manifestation and long-term prognosis of patients with systemic lupus erythematosus.
Modern rheumatology / the Japan Rheumatism Association 2005;15(4):275-82.
2004: Shinji Morimoto; Yoshiaki Tokano
[Alpha1-acid glycoprotein (alpha1-AG)].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 11():230-2.
2003: Yutaka Nakiri; Hiroshi Kaneko; Shinji Morimoto; Jun Suzuki; Yoshiaki Tokano; Hiroshi Hashimoto
Expression of NKB1 on peripheral T cells in patients with rheumatoid arthritis.
Clinical rheumatology 2003;22(4-5):305-8.
2003: Iwao Sekigawa; Yoshiaki Tokano; T Yoshiike; Noboru Iida; Hiroshi Hashimoto; H Ogawa
Relationship between serum IgE and autoantibody levels in SLE patients.
Clinical and experimental rheumatology 2003;21(5):683.
2003: Zhiquan Xu; Ken Takeuchi; Ran Matsudaira; Yoshinori Kanai; Yoshiaki Tokano; Yoshinari Takasaki; Hiroshi Hashimoto
[The comparison in double immunodiffusion and western blotting methods of anti-SS-A/B antibodies in patients with Sjögren's syndrome].
Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology 2003;26(2):74-9.
2002: Kazunori Sugimoto; Shinji Morimoto; Hiroyuki Kaneko; Kazuhisa Nozawa; Yoshiaki Tokano; Yoshinari Takasaki; Hiroshi Hashimoto
Decreased IL-4 producing CD4+ T cells in patients with active systemic lupus erythematosus-relation to IL-12R expression.
Autoimmunity 2002;35(6):381-7.
2002: Yoshiaki Tokano; Jun Suzuki; Hirofumi Amano; Kazuhisa Nozawa; Shinji Morimoto; Hiroshi Hashimoto
Increased levels of interleukin-18 in patients with systemic lupus erythematosus: comment on the article by Shibatomi et al.
Arthritis and rheumatism 2002;46(5):1410-1; author reply 1411-2.
2001: J Suzuki; S Morimoto; H Amano; Yoshiaki Tokano; Yoshinari Takasaki; Hiroshi Hashimoto
Serum levels of interleukin 15 in patients with rheumatic diseases.
The Journal of rheumatology 2001;28(11):2389-91.
2001: Shinji Morimoto; Yoshiaki Tokano; Hiroshi Kaneko; Kazuhisa Nozawa; Hirofumi Amano; Hiroshi Hashimoto
The increased interleukin-13 in patients with systemic lupus erythematosus: relations to other Th1-, Th2-related cytokines and clinical findings.
Autoimmunity 2001;34(1):19-25.
2000: S Morimoto; Yumiko Kanno; Y Tanaka; Yoshiaki Tokano; H Hashimoto; Serge Jacquot; Chikao Morimoto; Stuart F Schlossman; H Yagita; Ko Okumura; Tetsuji Kobata
CD134L engagement enhances human B cell Ig production: CD154/CD40, CD70/CD27, and CD134/CD134L interactions coordinately regulate T cell-dependent B cell responses.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(8):4097-104.
2000: Hirofumi Amano; Shinji Morimoto; Hiroshi Kaneko; Yoshiaki Tokano; Yoshinari Takasaki; Hiroshi Hashimoto
Effect of intravenous cyclophosphamide in systemic lupus erythematosus: relation to lymphocyte subsets and activation markers.
Lupus 2000;9(1):26-32.
1999: Yoshiaki Tokano; Hiroshi Hashimoto
[Alpha 1-acid glycoprotein (alpha 1-AG)].
Nihon rinsho. Japanese journal of clinical medicine 1999;57 Suppl():250-2.
1999: Yoshiaki Tokano; Shinji Morimoto; Hiroshi Kaneko; Hirofumi Amano; Kazuhisa Nozawa; Yoshinari Takasaki; Hiroshi Hashimoto
Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)--relation to Th1- and Th2-derived cytokines.
Clinical and experimental immunology 1999;116(1):169-73.
1999: Hiroshi Kaneko; Hitoshi Ogasawara; Toshio Naito; H Akimoto; S Lee; Takashi Hishikawa; Iwao Sekigawa; Yoshiaki Tokano; Yoshinari Takasaki; Sachiko Hirose; Hiroshi Hashimoto
Circulating levels of beta-chemokines in systemic lupus erythematosus.
The Journal of rheumatology 1999;26(3):568-73.
1999: Yoshinari Takasaki; K Abe; Yoshiaki Tokano; Hiroshi Hashimoto
The expression of LFA-1, ICAM-1, CD80 and CD86 molecules in lupus patients: implication for immunotherapy.
Internal medicine (Tokyo, Japan) 1999;38(2):175-7.
1998: S Lee; Hiroshi Kaneko; Iwao Sekigawa; Yoshiaki Tokano; Y Takasaki; Hiroshi Hashimoto
Circulating interleukin-16 in systemic lupus erythematosus.
British journal of rheumatology 1998;37(12):1334-7.
1998: Hiroshi Hashimoto; K Yamanaka; Yoshiaki Tokano; Noboru Iida; Yoshinari Takasaki; K Kabasawa; Y Nishimura
HLA-DRB1 alleles and beta 2 glycoprotein I-dependent anticardiolipin antibodies in Japanese patients with systemic lupus erythematosus.
Clinical and experimental rheumatology 1998;16(4):423-7.
1998: Yoshinari Takasaki; M Ogaki; K Abe; Ken Takeuchi; S Ando; Yoshiaki Tokano; Shigeto Kobayashi; Iwao Sekigawa; Hiroshi Tsuda; Hiroshi Hashimoto
Expression of costimulatory molecule CD80 on peripheral blood T cells in patients with systemic lupus erythematosus.
The Journal of rheumatology 1998;25(6):1085-91.
1998: Iwao Sekigawa; H Ogasawara; M Sugiyama; H Kaneko; Takashi Hishikawa; Yoshiaki Tokano; Noboru Iida; H Hahimoto; S Hirose
Extremely low dose treatment of cyclosporine for autoimmune diseases.
Clinical and experimental rheumatology 1998;16(3):352.
1998: Hitoshi Ogasawara; A Murashima; H Kaneko; Takashi Hishikawa; Yoshiaki Tokano; Iwao Sekigawa; Noboru Iida; Hiroshi Hashimoto; Sachiko Hirose
Effect of low-dose cyclosporin treatment on interstitial pneumonitis associated with Sjögren's syndrome.
British journal of rheumatology 1998;37(3):348-9.
1998: M Sugiyama; Iwao Sekigawa; Yoshiaki Tokano; N Iida; H Hashimoto; S Hirose
Effective treatment of autoimmune diseases with extremely low dose cyclosporine.
Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology 1998;21(1):20-8.
1998: Hitoshi Ogasawara; M Sekiya; A Murashima; Takashi Hishikawa; Yoshiaki Tokano; Iwao Sekigawa; Noboru Iida; Hiroshi Hashimoto; Sachiko Hirose
Very low-dose cyclosporin treatment of steroid-resistant interstitial pneumonitis associated with Sjögren's syndrome.
Clinical rheumatology 1998;17(2):160-2.
1997: M Tsujimura; Ken Yamaji; Yoshiaki Tokano; M Sugawara; Shigeto Kobayashi; Yoshinari Takasaki; Hiroshi Hashimoto; Shunichi Hirose
[A case of reactive arthritis fallen after shigellosis infection].
Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology 1997;20(5):453-6.
1997: Kazuhisa Nozawa; N Kayagaki; Yoshiaki Tokano; Hideo Yagita; Ko Okumura; H Hasimoto
Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases.
Arthritis and rheumatism 1997;40(6):1126-9.
1997: M Tsujimura; Yoshiaki Tokano; Yoshinari Takasaki; Hiroshi Hashimoto
[The relation between IgG subclasses and clinical manifestations in patients with active systemic lupus erythematosus].
Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology 1997;20(1):8-13.
1997: Yoshiaki Tokano; S Endo; F Hayashi; S Harada; Shigeto Kobayashi; Hiroshi Tsuda; Yoshinari Takasaki; Y Kyogoku; Y Arata; Ko Okumura; Hiroshi Hashimoto; Sachiko Hirose
A hidden immunoglobulin G2 in patients with rheumatoid arthritis detected by nuclear magnetic resonance.
The Journal of rheumatology 1997;24(2):275-81.
1997: Yoshiaki Tokano; Shinji Morimoto; Takashi Hishikawa; A Murashima; M Abe; Iwao Sekigawa; Yoshinari Takasaki; Hiroshi Hashimoto; Ko Okumura; T Shirai; Sachiko Hirose
Subsets of activated T cells in patients with systemic lupus erythematosus: the relation to cell cycle.
Scandinavian journal of rheumatology 1997;26(1):37-42.
1996: Yoshiaki Tokano; S Miyake; Nobuhiko Kayagaki; Kazuhisa Nozawa; S Morimoto; Miyuki Azuma; Hideo Yagita; Yoshinari Takasaki; K Okumura; Hiroshi Hashimoto
Soluble Fas molecule in the serum of patients with systemic lupus erythematosus.
Journal of clinical immunology 1996;16(5):261-5.
1996: Hiroshi Kaneko; Yoshiaki Tokano; Hiroshi Hashimoto; Sachiko Hirose
The expression of lymphocyte function associated antigen-1, intercellular adhesion molecule-1 on peripheral blood lymphocytes in patients with systemic lupus erythematosus.
Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology 1996;19(1):60-8.
1995: K Koshino; Yoshiaki Tokano; Takashi Hishikawa; Iwao Sekigawa; Yoshinari Takasaki; Hiroshi Hashimoto
Detection of antibodies to HIV-1 gp41- and HLA class II antigen-derived peptides in SLE patients.
Scandinavian journal of rheumatology 1995;24(5):288-92.
1994: Hiroshi Hashimoto; Y Nishimura; R P Dong; A Kimura; T Sasazuki; K Yamanaka; Yoshiaki Tokano; A Murashima; K Kabasawa; Sachiko Hirose
HLA antigens in Japanese patients with systemic lupus erythematosus.
Scandinavian journal of rheumatology 1994;23(4):191-6.
1994: Yoshiaki Tokano; Sachiko Hirose
[Progressive systemic sclerosis].
Ryōikibetsu shōkōgun shirīzu 1994;(4):537-9.
1994: Yoshiaki Tokano; Y Umezawa; K Okumura
Determination of IgG subclasses of immunoglobulin preparations for intravenous injection and the problems involved.
Immunologic research 1994;13(1):56-60.
1993: Yoshiaki Tokano; Hiroshi Kaneko; T Obara; Hiroshi Hashimoto; K Okumura; Sachiko Hirose
Soluble CD4 and CD8 molecules in patients with systemic sclerosis.
Clinical rheumatology 1993;12(4):490-3.
1993: Yoshiaki Tokano; T Obara; Hiroshi Hashimoto; K Okumura; Sachiko Hirose
Soluble CD4, CD8 in patients with polymyositis/dermatomyositis.
Clinical rheumatology 1993;12(3):368-74.
1993: Shigemasa Sawada; Hiroshi Hashimoto; S Iijma; Yoshiaki Tokano; Yoshihiro Matsukawa; Masami Takei; H Ishikawa; H Kang; K Tomura; K Mitamura
Increased soluble IL-2 receptor in serum of patients with systemic lupus erythematosus.
Clinical rheumatology 1993;12(2):204-9.
1993: Shigemasa Sawada; Hiroshi Hashimoto; S Iijima; Yoshiaki Tokano; Masami Takei; M Shida; T Obara
Immunologic significance of increased soluble CD8/CD4 molecules in patients with active systemic lupus erythematosus.
Journal of clinical laboratory analysis 1993;7(3):141-6.
1993: Yoshinori Kanai; Yoshiaki Tokano; Hiroshi Tsuda; Hiroshi Hashimoto; K Okumura; Sachiko Hirose
HLA-DP positive T cells in patients with polymyositis/dermatomyositis.
The Journal of rheumatology 1993;20(1):77-9.
1992: Yoshiaki Tokano; Yoshinori Kanai; Hiroshi Hashimoto; K Okumura; Sachiko Hirose
Soluble interleukin 2 receptors in patients with polymyositis/dermatomyositis.
Annals of the rheumatic diseases 1992;51(6):781-2.
1991: Yoshiaki Tokano; M Yasuma; S Harada; Yoshinari Takasaki; Hiroshi Hashimoto; K Okumura; Sachiko Hirose
Clinical significance of IgG subclasses of Anti-Sm and U1 ribonucleoprotein antibodies in patients with systemic lupus erythematosus and mixed connective tissue disease.
Journal of clinical immunology 1991;11(6):317-25.
1990: Takashi Hishikawa; Yoshiaki Tokano; Iwao Sekigawa; S Ando; Yoshinari Takasaki; Hiroshi Hashimoto; Sachiko Hirose; K Okumura; Masaaki Abe; T Shirai
HLA-DP+ T cells and deficient interleukin-2 production in patients with systemic lupus erythematosus.
Clinical immunology and immunopathology 1990;55(2):285-96.
1990: Yoshiaki Tokano; Hiroshi Hashimoto; Sachiko Hirose
[Interstitial lung disease in systemic lupus erythematosus, progressive systemic sclerosis and dermatomyositis].
Nihon rinsho. Japanese journal of clinical medicine 1990;48(3):530-4.
1990: Yoshiaki Tokano; Takashi Hishikawa; Tomohiko Hirose; Iwao Sekigawa; Hiroshi Hashimoto; K Okumura; Sachiko Hirose
HLA-DP-positive T cells in patients with systemic lupus erythematosus.
Autoimmunity 1990;5(3):179-83.
1989: Yoshiaki Tokano; A Murashima; Yoshinari Takasaki; Hiroshi Hashimoto; K Okumura; Sachiko Hirose
Relation between soluble interleukin 2 receptor and clinical findings in patients with systemic lupus erythematosus.
Annals of the rheumatic diseases 1989;48(10):803-9.
1989: Yoshiaki Tokano; S Arai; Hiroshi Hashimoto; Sachiko Hirose; Hideo Yagita; H Nakauchi; Y Kumagai; Y Arata; K Okumura
The distinct subgroup of patients with rheumatoid arthritis shown by Ig G3-reactive rheumatoid factor.
Autoimmunity 1989;5(1-2):107-14.
1988: Yoshiaki Tokano; Hideo Yagita; N Iida; Hiroshi Hashimoto; K Okumura; Sachiko Hirose
Relation between the level of IgG subclasses and infections in patients with systemic lupus erythematosus.
International archives of allergy and applied immunology 1988;87(1):55-8.